SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells
about
Splicing Regulation: A Molecular Device to Enhance Cancer Cell AdaptationPosttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell BiologyThe role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progressionMass spectrometry-based secretome analysis of non-small cell lung cancer cell lines.Caspase-9: structure, mechanisms and clinical applicationFrom General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform.Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells.Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer.Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosisAlternative RNA splicing and cancerCeramide kinase regulates the production of tumor necrosis factor α (TNFα) via inhibition of TNFα-converting enzyme.The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA.hnRNP U enhances caspase-9 splicing and is modulated by AKT-dependent phosphorylation of hnRNP LSRSF1 and SRSF9 RNA binding proteins promote Wnt signalling-mediated tumorigenesis by enhancing β-catenin biosynthesisEvaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia.Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung TumorigenesisFar upstream element-binding protein 1 and RNA secondary structure both mediate second-step splicing repression.Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy.Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer.Hallmarks of alternative splicing in cancer.Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells.Modulation of alternative splicing by anticancer drugs.Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems.Alternative splicing and cell survival: from tissue homeostasis to disease.A purine-rich element in foamy virus pol regulates env splicing and gag/pol expression.Protein kinase a-dependent phosphorylation of serine 119 in the proto-oncogenic serine/arginine-rich splicing factor 1 modulates its activity as a splicing enhancer proteinMelanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKCδ Signaling Axis.Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.DNA-methylation-mediated repression of miR-766-3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma.Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment.Moringa oleifera Gold Nanoparticles Modulate Oncogenes, Tumor Suppressor Genes, and Caspase-9 Splice Variants in A549 Cells.Modulation of alternative splicing induced by paclitaxel in human lung cancer.Multitasking β-catenin: from adhesion and transcription to RNA regulation
P2860
Q26798148-4F4D5C75-B904-4929-BF0C-A60E2A80F326Q26798154-719E65AC-C19B-47A0-A823-584B51FE224DQ28083838-416D023C-CEC0-4CF2-BA8C-54632C3E8CE2Q30313775-A7FA543D-F5BA-4B98-9317-79D45A7E3C9DQ33618946-8C11D262-3EC2-407B-BB56-60D8BF94023EQ34048030-62A67C7A-4C02-4FC9-B11F-AC00B2449FC8Q34302149-3EE01326-66C0-4486-9DD5-B7C286E6DB38Q34372539-DBCA2A68-1A99-4EE3-80E0-D2DD86BA8CC4Q35086962-197A7C82-6470-4C41-8423-C9EC6D4F19F8Q35442986-8C0172B4-875E-45A2-93D5-8ECBCAF3FAACQ35589667-0C752A1C-FD23-421B-8DC1-79C3D88D148DQ35604572-8C502481-19D3-4F8E-8EAC-6024579CE459Q35973562-D56C08D9-B9A5-429B-A36C-9DA28F9E9C9EQ36708640-6F5F4CC9-5EDF-4C6B-91C5-18589CD207D2Q36870110-EE1557FB-4603-4C54-A809-D80F9620B8BEQ36871720-43142D5F-9F0B-42BB-966D-A4D7EE9B1357Q36921618-190B654A-0C26-4970-84FC-40E1663E0745Q37031803-D4219FA5-A310-4CD1-9EE0-6EBDD37350C6Q37304724-70872E51-E32E-45AA-8203-166F5DAFFB2AQ37377166-6E2F515E-0851-47CF-B307-CDA2551AB072Q38171229-00832017-810E-4C41-A2DF-5CEDD9FCC27BQ38297287-27D1F670-24BD-4155-BEF8-E3A3F530CCDAQ38443362-FA945150-866F-403F-BE6A-5190749ED72CQ38735423-847678FE-667C-493B-89AF-0CC9A491414CQ38968877-4026A2EA-26E2-475C-B2B5-10433ADD0AC6Q40347732-554E5BB5-F0E0-4FD2-818A-E6893E2E19F7Q41094983-EE364C81-B4AA-415E-B891-D557707ED65CQ42380691-1F3FD4ED-6C7E-40B5-9D2C-B9E60F947299Q47784889-094B081A-B0E5-4AF4-8233-3DCB7D42F45FQ48212199-5BCC7FAA-3C4E-4E9D-8EED-42B53278069BQ49519966-8C210866-E2DE-4A25-A623-C0C6A93E3F1CQ50428851-2C62E845-88CB-482E-BB4B-F8018B4F40BCQ55036943-4B0C526E-D5DE-4A6A-BE48-E9EC868CE3E0Q58158336-A4821A03-395E-4568-95BA-F9583EBF879F
P2860
SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
SRSF1 regulates the alternativ ...... n-small cell lung cancer cells
@ast
SRSF1 regulates the alternativ ...... n-small cell lung cancer cells
@en
type
label
SRSF1 regulates the alternativ ...... n-small cell lung cancer cells
@ast
SRSF1 regulates the alternativ ...... n-small cell lung cancer cells
@en
prefLabel
SRSF1 regulates the alternativ ...... n-small cell lung cancer cells
@ast
SRSF1 regulates the alternativ ...... n-small cell lung cancer cells
@en
P2093
P2860
P1476
SRSF1 regulates the alternativ ...... n-small cell lung cancer cells
@en
P2093
Amy J Hawkins
Autumn Massiello
Charles E Chalfant
Charuta S Murudkar
Dayanjan S Wijesinghe
Eric K Mayton
Jacqueline C Shultz
Margaret A Park
Prabhat Mukerjee
Rachel W Goehe
P2860
P304
P356
10.1158/1541-7786.MCR-11-0061
P577
2011-05-26T00:00:00Z